Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers: a Double-blind, Randomised, Placebo-controlled, Crossover Study Within the Shift2Health Project

NCT07440147 is registered in ClinicalTrials.gov with FH Joanneum Gesellschaft mbH as lead sponsor.

NCT NCT07440147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07440147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers: a Double-blind, Randomised, Placebo-controlled, Crossover Study Within the Shift2Health Project
Lead sponsor
FH Joanneum Gesellschaft mbH
Phase
Not applicable
Overall status
Recruiting
Start date
January 20, 2026
Completion date
February 29, 2028
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circadian rhythm disorders, gut microbiota modulation, obesity & overweight, prediabetes (insulin resistance, impaired glucose tolerance)